체외수정(IVF) 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2024-2034년)
In Vitro Fertilization Market (Product: Equipment, Reagents & Media, and Accessories; and Type: Conventional IVF, IVF with ICSI, and IVF with Donor Eggs) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034
상품코드:1487583
리서치사:Transparency Market Research
발행일:2024년 04월
페이지 정보:영문 170 Pages
라이선스 & 가격 (부가세 별도)
한글목차
체외수정(IVF) 시장 - 조사 범위
TMR의 세계 체외수정(IVF) 시장에 대한 조사 보고서는 2024년부터 2034년까지의 예측 기간 동안 시장 지표에 대한 귀중한 통찰력을 얻기 위해 과거뿐만 아니라 현재의 성장 동향과 기회를 조사했습니다. 이 보고서는 2024년을 기준연도로, 2034년을 예측 연도로 하여 2018년부터 2034년까지 전 세계 체외수정(IVF) 시장의 수익과 예측을 제공합니다. 또한 2024년부터 2034년까지 세계 체외수정(IVF) 시장의 연평균 성장률(CAGR%)도 제시합니다.
이 보고서는 광범위한 조사 끝에 작성되었으며, 1차 조사에서 분석가들은 KOL(Key Opinion Leader), 업계 리더 및 오피니언 제조업체를 인터뷰하고, 2차 조사에서는 IVF 시장을 이해하기 위해 주요 기업의 제품 자료, 연례 보고서, 보도 자료 및 관련 문서를 참조했습니다. 관련 문서를 참고했습니다.
시장 현황
2023년 시장 규모
7억 8,110만 달러
2034년 시장 가치
1.5억 달러
CAGR
6.2%
이 보고서는 세계 체외수정(IVF) 시장의 경쟁 환경에 대해 심층적으로 분석합니다. 세계 체외수정(IVF) 시장에서 사업을 운영하는 주요 기업들이 확인되었으며, 각 기업들은 다양한 속성으로 프로파일링되었습니다. 기업 개요, 재무 상태, 최근 동향 및 SWOT는 이 보고서에서 다루는 세계 체외수정(IVF) 시장 기업의 속성입니다.
목차
제1장 서문
제2장 전제조건과 조사 방법
제3장 주요 요약 : 세계 시장
제4장 시장 개요
서론
시장 개요
시장 역학
세계 시장 분석과 예측, 2020년-2034년
제5장 주요 인사이트
파이프라인 분석
주요 제품/브랜드 분석
주요 M&A
COVID-19 팬데믹의 산업에 대한 영향
제6장 세계 시장 분석과 예측 : 제품별
서론과 정의
주요 조사 결과/발전
시장 매출 예측 : 제품별, 2020년-2034년
기기
시약·배지
액세서리
시장의 매력 : 제품별
제7장 세계 시장 분석과 예측 : 사이클별
서론과 정의
주요 조사 결과/발전
시장 매출 예측 : 사이클별, 2020년-2034년
신선비 기증자 사이클
동결비 기증자 IVF 사이클
동결 기증자 IVF 사이클
신선 기증자 IVF 사이클
시장의 매력 : 사이클 별
제8장 세계 시장 분석과 예측 : 유형별
서론과 정의
주요 조사 결과/발전
시장 매출 예측 : 유형별, 2020년-2034년
Conventional IVF
현미수정에 의한 IVF
기증자 난자에 의한 IVF
시장의 매력 : 유형별
제9장 세계 시장 분석과 예측 : 최종사용자별
서론과 정의
주요 조사 결과/발전
시장 매출 예측 : 최종사용자별, 2020년-2034년
불임 치료 클리닉
병원·수술센터
쿠라이오반크＆연구기관
시장의 매력 : 최종사용자별
제10장 세계 시장 분석과 예측 : 지역별
주요 조사 결과
시장 매출 예측 : 지역별, 2020년-2034년
북미
유럽
아시아태평양
라틴아메리카
중동 및 아프리카
시장의 매력 : 지역별
제11장 북미 시장 분석과 예측
제12장 유럽 시장 분석과 예측
제13장 아시아태평양 시장 분석과 예측
제14장 라틴아메리카 시장 분석과 예측
제15장 중동 및 아프리카 시장 분석과 예측
제16장 경쟁 구도
시장 경쟁 매트릭스(기업 Tier별, 기업 규모별)
시장 점유율 분석 : 기업별(2023년)
기업 개요
Vitrolife AB
Cook Medical
Thermo Fisher Scientific, Inc.
Merck KGAA
Ovascience, Inc.
CooperSurgical
Genea Ltd.
Rocket Medical PLC
Fertility Focus Ltd.
LSH
영문 목차
영문목차
In Vitro Fertilization Market - Scope of Report
TMR's report on the global in vitro fertilization market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global in vitro fertilization market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global in vitro fertilization market from 2024 to 2034.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the in vitro fertilization market.
Market Snapshot
Market Value in 2023
US$ 781.1 Mn
Market Value in 2034
US$ 1.5 Bn
CAGR
6.2%
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global in vitro fertilization market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global in vitro fertilization market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global in vitro fertilization market.
The report delves into the competitive landscape of the global in vitro fertilization market. Key players operating in the global in vitro fertilization market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global in vitro fertilization market profiled in this report.
Key Questions Answered in Global in vitro fertilization Market Report:
What is the sales/revenue generated by in vitro fertilization across all regions during the forecast period?
What are the opportunities in the global in vitro fertilization market?
What are the major drivers, restraints, opportunities, and threats in the market?
Which regional market is set to expand at the fastest CAGR during the forecast period?
Which segment is expected to generate the highest revenue globally in 2034?
Which segment is projected to expand at the highest CAGR during the forecast period?
What are the market positions of different companies operating in the global market?
In Vitro Fertilization Market - Research Objectives and Research Approach
The comprehensive report on the global in vitro fertilization market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global in vitro fertilization market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global in vitro fertilization market.
Table of Contents
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global In Vitro Fertilization Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global In Vitro Fertilization Market Analysis and Forecast, 2020-2034
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global In Vitro Fertilization Market Analysis and Forecast, by Product
6.1. Introduction and Definitions
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product, 2020-2034
6.3.1. Equipment
6.3.2. Reagents & Media
6.3.3. Accessories
6.4. Market Attractiveness, by Product
7. Global In Vitro Fertilization Market Analysis and Forecast, by Cycle
7.1. Introduction and Definitions
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Cycle, 2020-2034
7.3.1. Fresh Non-donor Cycle
7.3.2. Frozen Non-donor IVF Cycle
7.3.3. Frozen donor IVF Cycle
7.3.4. Fresh donor IVF Cycle
7.4. Market Attractiveness, by Cycle
8. Global In Vitro Fertilization Market Analysis and Forecast, by Type
8.1. Introduction and Definitions
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Type, 2020-2034
8.3.1. Conventional IVF
8.3.2. IVF with ICSI
8.3.3. IVF with Donor Eggs
8.4. Market Attractiveness, by Type
9. Global In Vitro Fertilization Market Analysis and Forecast, by End-user
9.1. Introduction and Definitions
9.2. Key Findings/Developments
9.3. Market Value Forecast, by End-user, 2020-2034
9.3.1. Fertility Clinics
9.3.2. Hospitals & Surgical Centers
9.3.3. Cryobanks & Research Institutes
9.4. Market Attractiveness, by End-user
10. Global In Vitro Fertilization Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Market Value Forecast, by Region, 2020-2034
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness, by Region
11. North America In Vitro Fertilization Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product, 2020-2034
11.2.1. Equipment
11.2.2. Reagents & Media
11.2.3. Accessories
11.3. Market Attractiveness, by Product
11.4. Market Value Forecast, by Cycle, 2020-2034
11.4.1. Fresh Non-donor Cycle
11.4.2. Frozen Non-donor IVF Cycle
11.4.3. Frozen donor IVF Cycle
11.4.4. Fresh donor IVF Cycle
11.5. Market Attractiveness, by Cycle
11.6. Market Value Forecast, by Type, 2020-2034
11.6.1. Conventional IVF
11.6.2. IVF with ICSI
11.6.3. IVF with Donor Eggs
11.7. Market Attractiveness, by Type
11.8. Market Value Forecast, by End-user, 2020-2034
11.8.1. Fertility Clinics
11.8.2. Hospitals & Surgical Centers
11.8.3. Cryobanks & Research Institutes
11.9. Market Attractiveness, by End-user
11.10. Market Value Forecast, by Country/Sub-region, 2020-2034
11.10.1. U.S.
11.10.2. Canada
11.11. Market Attractiveness Analysis
11.11.1. By Product
11.11.2. By Cycle
11.11.3. By Type
11.11.4. By End-user
11.11.5. By Country
12. Europe In Vitro Fertilization Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product, 2020-2034
12.2.1. Equipment
12.2.2. Reagents & Media
12.2.3. Accessories
12.3. Market Attractiveness, by Product
12.4. Market Value Forecast, by Cycle, 2020-2034
12.4.1. Fresh Non-donor Cycle
12.4.2. Frozen Non-donor IVF Cycle
12.4.3. Frozen donor IVF Cycle
12.4.4. Fresh donor IVF Cycle
12.5. Market Attractiveness, by Cycle
12.6. Market Value Forecast, by Type, 2020-2034
12.6.1. Conventional IVF
12.6.2. IVF with ICSI
12.6.3. IVF with Donor Eggs
12.7. Market Attractiveness, by Type
12.8. Market Value Forecast, by End-user, 2020-2034
12.8.1. Fertility Clinics
12.8.2. Hospitals & Surgical Centers
12.8.3. Cryobanks & Research Institutes
12.9. Market Attractiveness, by End-user
12.10. Market Value Forecast, by Country/Sub-region, 2020-2034
12.10.1. Germany
12.10.2. U.K.
12.10.3. France
12.10.4. Italy
12.10.5. Spain
12.10.6. Rest of Europe
12.11. Market Attractiveness Analysis
12.11.1. By Product
12.11.2. By Cycle
12.11.3. By Type
12.11.4. By End-user
12.11.5. By Country/Sub-region
13. Asia Pacific In Vitro Fertilization Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product, 2020-2034
13.2.1. Equipment
13.2.2. Reagents & Media
13.2.3. Accessories
13.3. Market Attractiveness, by Product
13.4. Market Value Forecast, by Cycle, 2020-2034
13.4.1. Fresh Non-donor Cycle
13.4.2. Frozen Non-donor IVF Cycle
13.4.3. Frozen donor IVF Cycle
13.4.4. Fresh donor IVF Cycle
13.5. Market Attractiveness, by Cycle
13.6. Market Value Forecast, by Type, 2020-2034
13.6.1. Conventional IVF
13.6.2. IVF with ICSI
13.6.3. IVF with Donor Eggs
13.7. Market Attractiveness, by Type
13.8. Market Value Forecast, by End-user, 2020-2034
13.8.1. Fertility Clinics
13.8.2. Hospitals & Surgical Centers
13.8.3. Cryobanks & Research Institutes
13.9. Market Attractiveness, by End-user
13.10. Market Value Forecast, by Country/Sub-region, 2020-2034
13.10.1. China
13.10.2. Japan
13.10.3. India
13.10.4. Australia & New Zealand
13.10.5. Rest of Asia Pacific
13.11. Market Attractiveness Analysis
13.11.1. By Product
13.11.2. By Cycle
13.11.3. By Type
13.11.4. By End-user
13.11.5. By Country/Sub-region
14. Latin America In Vitro Fertilization Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product, 2020-2034
14.2.1. Equipment
14.2.2. Reagents & Media
14.2.3. Accessories
14.3. Market Attractiveness, by Product
14.4. Market Value Forecast, by Cycle, 2020-2034
14.4.1. Fresh Non-donor Cycle
14.4.2. Frozen Non-donor IVF Cycle
14.4.3. Frozen donor IVF Cycle
14.4.4. Fresh donor IVF Cycle
14.5. Market Attractiveness, by Cycle
14.6. Market Value Forecast, by Type, 2020-2034
14.6.1. Conventional IVF
14.6.2. IVF with ICSI
14.6.3. IVF with Donor Eggs
14.7. Market Attractiveness, by Type
14.8. Market Value Forecast, by End-user, 2020-2034
14.8.1. Fertility Clinics
14.8.2. Hospitals & Surgical Centers
14.8.3. Cryobanks & Research Institutes
14.9. Market Attractiveness, by End-user
14.10. Market Value Forecast, by Country/Sub-region, 2020-2034
14.10.1. Brazil
14.10.2. Mexico
14.10.3. Rest of Latin America
14.11. Market Attractiveness Analysis
14.11.1. By Product
14.11.2. By Cycle
14.11.3. By Type
14.11.4. By End-user
14.11.5. By Country/Sub-region
15. Middle East & Africa In Vitro Fertilization Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Product, 2020-2034
15.2.1. Equipment
15.2.2. Reagents & Media
15.2.3. Accessories
15.3. Market Attractiveness, by Product
15.4. Market Value Forecast, by Cycle, 2020-2034
15.4.1. Fresh Non-donor Cycle
15.4.2. Frozen Non-donor IVF Cycle
15.4.3. Frozen donor IVF Cycle
15.4.4. Fresh donor IVF Cycle
15.5. Market Attractiveness, by Cycle
15.6. Market Value Forecast, by Type, 2020-2034
15.6.1. Conventional IVF
15.6.2. IVF with ICSI
15.6.3. IVF with Donor Eggs
15.7. Market Attractiveness, by Type
15.8. Market Value Forecast, by End-user, 2020-2034
15.8.1. Fertility Clinics
15.8.2. Hospitals & Surgical Centers
15.8.3. Cryobanks & Research Institutes
15.9. Market Attractiveness, by End-user
15.10. Market Value Forecast, by Country/Sub-region, 2020-2034
15.10.1. GCC Countries
15.10.2. South Africa
15.10.3. Rest of Middle East & Africa
15.11. Market Attractiveness Analysis
15.11.1. By Product
15.11.2. By Cycle
15.11.3. By Type
15.11.4. By End-user
15.11.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player - Competition Matrix (By Tier and Size of Companies)
16.2. Market Share Analysis, by Company (2023)
16.3. Company Profiles
16.3.1. Vitrolife AB
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Product Portfolio
16.3.1.3. Financial Overview
16.3.1.4. SWOT Analysis
16.3.1.5. Strategic Overview
16.3.2. Cook Medical
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Product Portfolio
16.3.2.3. Financial Overview
16.3.2.4. SWOT Analysis
16.3.2.5. Strategic Overview
16.3.3. Thermo Fisher Scientific, Inc.
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Product Portfolio
16.3.3.3. Financial Overview
16.3.3.4. SWOT Analysis
16.3.3.5. Strategic Overview
16.3.4. Merck KGAA
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Product Portfolio
16.3.4.3. Financial Overview
16.3.4.4. SWOT Analysis
16.3.4.5. Strategic Overview
16.3.5. Ovascience, Inc.
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Product Portfolio
16.3.5.3. Financial Overview
16.3.5.4. SWOT Analysis
16.3.5.5. Strategic Overview
16.3.6. CooperSurgical
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Product Portfolio
16.3.6.3. Financial Overview
16.3.6.4. SWOT Analysis
16.3.6.5. Strategic Overview
16.3.7. Genea Ltd.
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Product Portfolio
16.3.7.3. Financial Overview
16.3.7.4. SWOT Analysis
16.3.7.5. Strategic Overview
16.3.8. Rocket Medical PLC
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Product Portfolio
16.3.8.3. Financial Overview
16.3.8.4. SWOT Analysis
16.3.8.5. Strategic Overview
16.3.9. Fertility Focus Ltd.
16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
